Akebia Therapeutics (AKBA) Amortizatization of Intangibles (2014 - 2021)

Akebia Therapeutics (AKBA) has 8 years of Amortizatization of Intangibles data on file, last reported at $4000.0 in Q2 2021.

• On a quarterly basis, Amortizatization of Intangibles rose 100.0% year-over-year to $4000.0 in Q2 2021; TTM through Mar 2022 was $4000.0, a 93.1% decrease from a year earlier, with the FY2021 full-year figure at $15000.0, down 68.09% from the prior year.
• Amortizatization of Intangibles for Q2 2021 stood at $4000.0, down from $11000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for AKBA reached as high as $534000.0 in Q4 2018 and fell as low as -$198000.0 in Q2 2017.
• Historically, Amortizatization of Intangibles has averaged $88411.8 across 5 years, with a median of $24000.0 in 2019.
• Across the five-year window, Amortizatization of Intangibles surged 897.01% in 2018 and tumbled 99.04% in 2020, its largest moves.
• Year by year, Amortizatization of Intangibles stood at -$67000.0 in 2017, then jumped by 897.01% to $534000.0 in 2018, then plunged by 95.51% to $24000.0 in 2019, then plunged by 33.33% to $16000.0 in 2020, then slumped by 75.0% to $4000.0 in 2021.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $4000.0 in Q2 2021, $11000.0 in Q1 2021, and $16000.0 in Q4 2020.